3-Bromo-5-(trifluoromethoxy)pyridine, 98+%, 250mg

5-(Trifluoromethyl)thiazol-2-amine, 95.0%, 1g

(3-Fluoro-5-(hydroxymethyl)phenyl)boronic acid, 97%, 250mg

1-(2-Aminoethyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one hydrochloride, 95.0%, 1g

5-Chloro-3H-[1,2,3]triazolo[4,5-b]pyridine, 95.0%, 10g

4-(Hydroxymethyl)benzene-1,2-diol, 95.0%, 1g

3-Amino-5-hydroxypyridine, 98.0%, 100mg

5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, 95.0%, 100mg

2-(3-METHYLPHENYL)-1H-BENZO[D]IMIDAZOLE, 95.0%, 1g

GC capillary column ROTI®Cap-1 MS, 30 m, 0.25 mm, 0.25 µm, 1 Piece(s)

2-(1H-imidazol-1-yl)-5-nitropyridine, 97.0%, 5g

Sodium 3-amino-5-chloro-4-methylbenzenesulfonate, 97.0%, 25g

2-{3,5-dimethyl-1-[3-(trifluoromethyl)phenyl]-1h-pyrazol-4-yl}-2-oxoacetic acid, 97%, 100mg